Cochrane · systematic review · CD009672

Hormone therapy for sexual function in perimenopausal and postmenopausal women

Lara, LA, Cartagena-Ramos, D, Figueiredo, JBP, et al. · Cochrane Database of Systematic Reviews · 2023 · Cochrane Library

Gynaecology and Fertility2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
10
current version
GRADE rated
9
No studies
1
Included studies
NR
No studies 1 · 10%Ungraded 0 · 0%Very low 6 · 60%Low 1 · 10%Moderate 2 · 20%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Show all 2 versions

Hormonal therapy compared with placebo or no intervention for sexual function in symptomatic or early postmenopausal women

Population: symptomatic or early postmenopausal womena
5 questions
OutcomeEffectEvidenceStatus / GRADE
Estrogen aloneSexual function score measured by MENQoL sexual subscore (higher score = better sexual functioning); GCS sexual subscore (higher score = worse sexual functioning and for analysis, the scoring direction was reversed); and MSQ (higher ...
Hormonal therapy vs placebo or no intervention
no estimate extracted3 studies · 699 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency
Estrogen + progestogens
Hormonal therapy vs placebo or no intervention
no estimate extractedNRNo studies
Synthetic steroids Sexual function score measured by WHQ sexual subscore (higher score = better sexual functioning)
Hormonal therapy vs placebo or no intervention
no estimate extracted1 study · 883 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
SERMs Composite sexual function score measured by AESEX scale (higher score = worse sexual functioning and for analysis, the scoring direction was reversed)
Hormonal therapy vs placebo or no intervention
no estimate extracted1 study · 215 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
SERMs + estrogen Composite sexual function score measured by ASEX scale (higher score = worse sexual functioning and for analysis, the scoring direction was reversed)
Hormonal therapy vs placebo or no intervention
no estimate extracted1 study · 542 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency

Hormonal therapy compared with placebo or no intervention for sexual function in unselected postmenopausal women

Population: unselected postmenopausal womena
5 questions
OutcomeEffectEvidenceStatus / GRADE
Estrogen alone Sexual function score measured by FSFI (higher score = better sexual functioning); WHQ sexual subscore (higher score = better sexual functioning); MENQoL sexual subscore (higher score = better sexual functioning)
Hormonal therapy vs placebo or no intervention
no estimate extracted6 studies · 608 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency
Estrogen + progestogens Sexual function score measured by WHQ sexual subscore (higher score = better sexual functioning)
Hormonal therapy vs placebo or no intervention
no estimate extracted1 study · 104 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Synthetic steroids Sexual function score measured by FSFI; WHQ sexual subscore (higher score = better sexual functioning)
Hormonal therapy vs placebo or no intervention
no estimate extracted1 study · 105 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
SERMs Sexual function score measured by FSFI (higher score = better sexual functioning)
Hormonal therapy vs placebo or no intervention
no estimate extracted2 studies · 1525 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
SERMs + estrogen Sexual function score measured by MENQoL sexual subscore (higher score = better sexual functioning)
Hormonal therapy vs placebo or no intervention
no estimate extracted1 study · 272 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency